Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.March 10, 2026
‘I am stuck in a low-income trap’: I’m a teacher and very good at my job. Will I ever earn six figures?March 9, 2026
Share Facebook Twitter LinkedIn Pinterest Email Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat. Cowen downgrade duopoly ends maker Nordisk Novo Ozempic sight status
‘I am stuck in a low-income trap’: I’m a teacher and very good at my job. Will I ever earn six figures?March 9, 2026
‘I don’t own a home’: I’m 62, unemployed and have $1.5 million for retirement. Can I afford to divorce my husband?March 8, 2026
